The Power of Dry Granulation
Dry granulation uses mechanical force for powder agglomeration, bypassing liquids to protect heat- or moisture-sensitive drugs. Key processes include roller compaction, where powders form dense ribbons milled into uniform granules, and slugging for smaller batches. This approach ensures flowability improvement and compressibility enhancement for seamless production.
Octavius Pharma's Anti-Allergics DC Granules
Octavius Pharma leads with WHO GMP certified and ISO 9001:2015 compliant Anti-Allergics DC Granules, featuring Desloratadine Granules, Fexofenadine Premix, and Levocetirizine DC. These premix granules are engineered for direct use in tablets and capsules, streamlining manufacturing while maintaining API stability.
Case Study: Achieving Granulation Success
In a recent production run, Octavius Pharma's Anti-Allergics DC Granules achieved granulation success via roller compaction, yielding granules with superior flowability improvement (Hausner ratio <1.2) and compressibility enhancement. Tablets pressed directly met dissolution specs for Fexofenadine Premix, cutting process time by 30% over wet methods. This highlights dry granulation's edge for anti-allergy formulations.
Benefit | Dry Granulation with Octavius Pharma DC Granules |
Process Efficiency | Fewer steps, no drying needed |
API Protection | Ideal for moisture-sensitive anti-allergics |
Scalability | High-volume roller compaction compatibility |
Quality Assurance | WHO GMP and ISO 9001:2015 standards |
End-Product Performance | Enhanced tablet compression and uniformity |
Why Choose Octavius Pharma?
Octavius Pharma's DC Granules deliver granulation success by combining advanced powder agglomeration with rigorous compliance. For anti-allergics producers seeking reliable premix granules, these solutions optimize tablet compression and boost operational efficiency across global facilities.
